OpenAlex
PricingAboutJobs
Log inGet started
Work

Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency

HTML

Year: 2009
Type: article
Study design: Clinical Trial
Source: European Journal of Endocrinology
DOI: 10.1530/eje-08-0436
Authors: G S Conway, M Szarras-Czapnik, K Racz, A Keller, P Chanson, M Tauber, M Zacharin, _ _
Institutions: University College Hospital, University College London Hospitals NHS Foundation Trust, Children's Memorial Health Institute, Semmelweis University, Leipzig University, Assistance Publique – Hôpitaux de Paris, Bicêtre Hospital, Centre Hospitalier Universitaire de Toulouse, Hôpital des Enfants, Royal Children's Hospital
Language: English

Topic: Growth Hormone and Insulin-like Growth Factors
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: recombinant human growth hormone, growth hormone therapy, childhood-onset growth hormone deficiency, bone mineral density, young adults, lumbar spine, hip bone density, treatment discontinuation
SDG: Good health and well-being

Open Access status: closed

Funder: Novo Nordisk
OpenAlex ID: W2151739898
FWCI: 2.886
Cites: 62
Cited by: 71
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security